Sutent is indicated for the treatment of advanced/metastatic renal cell carcinoma (MRCC) in adults. Sutent is indicated for the treatment of unresectable or metastatic, well-differentiated pancreatic neuroendocrine tumours (pNET) with disease progression in adults.
| Strength | 50 mg |
| Packaging Details | 28 capsules |
| Prescription/Nonprescription | Prescription |
| Salt | Sunitinib Malate |
| Form | Capsule |
| Country of origin | Made in India |
Sutent is indicated for the treatment of advanced/metastatic renal cell carcinoma (MRCC) in adults. Sutent is indicated for the treatment of unresectable or metastatic, well-differentiated pancreatic neuroendocrine tumours (pNET) with disease progression in adults.
| Strength | 50 mg |
|---|---|
| Packaging Details | 28 capsules |
| Prescription/Nonprescription | Prescription |
| Salt | Sunitinib Malate |
| Form | Capsule |
| Country of origin | Made in India |
Reviews
There are no reviews yet.